Abstract
Objective To observe the inhibitory effects of construction of complement factor (CFB)small interference RNA (siRNA) on choroidal neovascularization(CNV)induced by photocoagulation in rats.Methods We constructed an expression vector of CFB-siRNA by cutting CFB-siRNA and plasmid pRNATU6.1/Neo.Experimental CNV was induced by photocoagulation in 42 Brown Norway rats.After the model was set up,the rats were randomly divided into tail intravenous injection,vitreous injection,subretinal injection,and control group;each group except the control one had a corresponding blank plasmid control group.CFB-siRNA was injected 1,3,and 5 days respectively after photocoagulation in the injection groups;the dosage was 50,20,and 10 μg in tail intravenous injection,vitreous injection,and subretinal injection group respectively,while no injection was give to the control group after photocoagulation.Before and 14 days after photocoagulation,fundus fluorescein angiograoph (FFA) was performed and CNV development was judged by the leakage;the expression of vascular endothelial growth factor (VEGF) and factor Ⅷ were detected by immunohistochemistry.Results The leakage of fluorescein was obvious lower in tail intravenous injection group than that in the control group (X~2=15.1620,P 0.05);while was apparently lower than that in the other groups at different time points (F=77.96,55.68;P<0.05).All of the groups,except tail intravenous injection group,had higher expression of VEGF and factor Ⅷ 14 days after photocoagulation compared with that 7 days after photocoagulation (F=60.89,61.12;P<0.05).Conclusions Constructed CFB-siRNA can inhibite CNV by down-regulating the expression of VEGF and factor Ⅷ. Key words: Choroidal neovascularization/ therapy; Gene therapy; RNA,small interfering; Disease models,animal
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.